Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study.

Saved in:
Bibliographic Details
Title: Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study.
Authors: Burchard J; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Polpitiya AD; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Fox AC; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Randolph TL; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Fleischer TC; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Dufford MT; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Garite TJ; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Critchfield GC; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Boniface JJ; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA., Saade GR; Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX 77555, USA., Kearney PE; Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA.
Source: Journal of clinical medicine [J Clin Med] 2021 Oct 29; Vol. 10 (21). Date of Electronic Publication: 2021 Oct 29.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2077-0383
DOI:10.3390/jcm10215088